Firefighter standing next to a female doctor in a firehouse next to a fire engine

The winter issue of Synthesis magazine is now available

Check out the digital version or order free print copies of UC Davis Comprehensive Cancer Center’s leading publication


The winter 2024 issue of Synthesis magazine is available. The biannual magazine of UC Davis Comprehensive Cancer Center shares the latest news about cancer science and advanced treatments helping to bring innovative cancer care to patients.

Cover of Winter 2024 Synthesis magazine

This issue’s cover story features a top UC Davis cancer researcher who has been awarded a $1.9 million grant to study lethal cancers in firefighters.

The magazine also includes a story on the new Canine Tumor Genome Atlas project. Learn about how the next-generation DNA sequencing of dog tumors may help unlock cancer breakthroughs for pets as well as people.

Readers will also find out about the cancer center’s new lung cancer clinic that links education and prevention with the latest diagnostics and surgical technologies to catch and treat lung cancer, the No. 1 cause of cancer deaths.

The new Synthesis also details a novel initiative focused on addressing cancer risks in persistent poverty areas. There’s also an article on the cancer center’s commitment to understanding the cancer burden endemic in Native American communities and the tribal outreach underway to help address these disparities.

Finally, the issue spotlights high-profile donors such as the Farrah Fawcett Foundation and Hyundai Motor America, which are making a difference at the only National Cancer Institute-designated comprehensive cancer center in inland Northern California.

These stories and many more can be found in the latest issue of Synthesis. Sign up to receive a free subscription to the print version of Synthesis, which is also available online. Questions or comments? Contact Synthesis editor Stephanie Winn at

UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists. For more information, visit